Condensed Consolidated Statements of Change in Stockholders' Equity (Deficiency) - USD ($) |
Total |
Non-employee stock compensation [Member] |
IPO [Member] |
Common Stock [Member] |
Common Stock [Member]
Non-employee stock compensation [Member]
|
Common Stock [Member]
Cashless exercise of warrants- non- employee stock compensation [Member]
|
Common Stock [Member]
IPO [Member]
|
Additional Paid-in Capital [Member] |
Additional Paid-in Capital [Member]
Non-employee stock compensation [Member]
|
Additional Paid-in Capital [Member]
Cashless exercise of warrants- non- employee stock compensation [Member]
|
Additional Paid-in Capital [Member]
IPO [Member]
|
Accumulated Deficit [Member] |
Accumulated Other Comprehensive (Loss) Income [Member] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beginning Balance at Jun. 30, 2021 | $ (6,520,253) | $ 103 | $ 1,504,950 | $ (7,969,726) | $ (55,580) | ||||||||
| Beginning Balance, shares at Jun. 30, 2021 | 10,312,585 | ||||||||||||
| Net loss | (2,773,441) | (2,773,441) | |||||||||||
| Issuance of common stock | $ 320,823 | $ 2 | $ 320,821 | ||||||||||
| Issuance of common stock, shares | 232,666 | ||||||||||||
| Foreign currency translation adjustment | (12,807) | (12,807) | |||||||||||
| Ending Balance at Sep. 30, 2021 | (8,985,678) | $ 105 | 1,825,771 | (10,743,167) | (68,387) | ||||||||
| Ending Balance, shares at Sep. 30, 2021 | 10,545,251 | ||||||||||||
| Beginning Balance at Jun. 30, 2022 | (15,596,559) | $ 105 | 4,020,552 | (19,715,740) | 98,524 | ||||||||
| Beginning Balance, shares at Jun. 30, 2022 | 10,545,251 | ||||||||||||
| Beneficial conversion feature from issuance of convertible note | 537,383 | 537,383 | |||||||||||
| Net loss | (3,672,348) | (3,672,348) | |||||||||||
| Issuance of common stock | 439,332 | $ 7,951,225 | $ 1 | $ 2 | $ 23 | 439,331 | $ (2) | $ 7,951,202 | |||||
| Issuance of common stock, shares | 109,833 | 157,143 | 2,300,000 | ||||||||||
| Conversion of convertible note payable | 14,097,414 | $ 38 | 14,097,376 | ||||||||||
| Conversion of convertible note payable, shares | 3,799,801 | ||||||||||||
| Conversion of convertible note payable, related parties | 2,437,574 | $ 4 | 2,437,570 | ||||||||||
| Conversion of convertible note payable, related parties, shares | 376,088 | ||||||||||||
| Issuance of warrants | $ 856,170 | $ 175,349 | $ 856,170 | $ 175,349 | |||||||||
| Foreign currency translation adjustment | (135,276) | (135,276) | |||||||||||
| Ending Balance at Sep. 30, 2022 | $ 7,090,264 | $ 173 | $ 30,514,931 | $ (23,388,088) | $ (36,752) | ||||||||
| Ending Balance, shares at Sep. 30, 2022 | 17,288,116 |
| X | ||||||||||
- Definition Stock issued during period shares issued for conversion of convertible note payable, related parties. No definition available.
|
| X | ||||||||||
- Definition Stock issued during period values issued for conversion of convertible note payable, related parties. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The gross value of stock issued during the period upon the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|